Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Francis J. Castellino has a total of 263 co-authors. Here are the top co-authors by number of shared publications:

  • Victoria A. Ploplis

    W. M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, USA

    40 shared publications
  • Zhong Liang

    W.M. Keck Center for Transgene Research, University of Notre Dame, Indiana 46556, USA

    28 shared publications
  • Shaun W. Lee

    Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA

    20 shared publications
  • Yetunde A. Ayinuola

    Department of Chemistry and Biochemistry and W. M. Keck Center for Transgene Research, University of Notre Dame, United States

    15 shared publications
  • Deborah L. Donahue

    W. M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, USA

    10 shared publications
  • Rashna D. Balsara

    W.M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, IN 46556, United States; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, United States

    10 shared publications

Latest Publications

  • Open Access

    Disulfide bonds stabilize the SARS-CoV-2 RBD and preserve binding to ACE2 following thermal denaturation

    by Nathan R. McCann, Francis J. Castellino

    The Spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mediates host cell attachment and entry through the binding of its cognate receptor, angiotensin-converting enzyme 2 (ACE2). This interaction occurs within the receptor-binding domain (RBD) of the Spike protein and is critical to the lifecycle and fitness of SARS-CoV-2. A rigorous analysis of this interaction is crucial to understanding this viral entry mechanism. In the present communication, a biophysical examination of the RBD, ACE2, and their interaction is presented. These studies led to the discovery that disulfide bonds stabilize and protect the RBD from thermal and chemical denaturation. It is further hypothesized that disulfide bond stabilization preserves the ability of the RBD to bind ACE2 following its denaturation. The present hypothesis is supported by the finding that the RBD retains ACE2-binding activity after treatment to high temperatures (95°C) under non-reducing, but not reducing, conditions. These results suggest a mechanism by which SARS-CoV-2 overcomes environmental stress to preserve its RBD–ACE2 interaction.

  • Open Access

    Fibrin-rich environment drives catheter-associated UTIs by suppressing macrophage defenses

    by Armando M. Marrufo, Christopher Gager, Jonathan J. Molina, Marissa J. Andersen, Alyssa A. La Bella, Jessica J. Kean, Katelyn C. Fealy, Elizabeth R. Lucas, Ellsa Wongso, Tamanna Urmi, et al.

    Catheter-associated urinary tract infections (CAUTIs) pose severe clinical challenges, often leading to urosepsis and multidrug resistance. The wound-healing process triggered by catheter-induced bladder damage deposits fibrinogen and its polymerized form, fibrin. However, uropathogens exploit the fibrinogen and fibrin matrix to form a protective biofilm. While catheter-induced inflammation recruits innate immune cells, particularly macrophages, to the site of infection, the persistence of uropathogens suggests that the local bladder environment alters their antimicrobial function. Our research pinpoints the coagulation cascade as a key driver of this dysfunction, finding a differential macrophage polarization influenced by fibrinogen and fibrin. We showed that urinary catheterization creates a fibrin-rich matrix that was correlated with polarizing macrophages into an anti-inflammatory M2-like state, suppressing their bactericidal response. In contrast, using mice expressing fibrinogen locked in the form of a monomer, we demonstrated that monomeric fibrinogen promotes a pro-inflammatory M1-like polarization state. Notably, skewing a M1-like macrophage state with GM-CSF failed to clear the infection and systemic dissemination, suggesting a dominant role for fibrin matrix in suppressing M1-like macrophage-mediated antimicrobial activity. Together, these findings show that the catheterized bladder provides signals that significantly alter macrophage function, creating an ideal niche for pathogen persistence.

  • Open Access

    A Novel Translational Reprogramming of the Insertion Sequence IS1239 by 1-bp Deletion Resulted in Polymorphism of C-Terminal Amino Acid Sequences in the Pathogenic Bacterium Streptococcus pyogenes

    by Yun-Juan Bao, Zhong Liang, Zhi-Song Chen, Francis J. Castellino

    Yun-Juan Bao, Zhong Liang, Zhi-Song Chen, and Francis J. Castellino. J. Microbiol. Biotechnol. 2026;36:1-10. https://doi.org/10.4014/jmb.2508.08039

  • Open Access

    Interactions between membrane-bound streptococcal alpha-enolase and human plasminogen captured through cryogenic-electron microscopy

    by Sheiny Tjia-Fleck, Bradley M. Readnour, Zhong Liang, Yetunde A. Ayinuola, Francis J. Castellino

    Certain invasive strains of the Gram-positive bacterium Streptococcus pyogenes exploit human plasminogen (hPg) to promote tissue invasion and pathogenesis. hPg is a single-chain multi-modular zymogen containing five kringle domains (K1-K5), four of which interact with lysine or pseudo-lysine residues on binding partners, positioning hPg for activation to plasmin and enhancing bacterial dissemination. The major hPg binding protein in S. pyogenes is the multicopy surface-resident M-protein, or other surface proteins, such as the homooctameric glycolytic enzyme, enolase (SEn). SEn lacks features for direct translocation from the cytoplasm to the bacterial surface, and it is unclear how Sen is translocated to the bacterial surface. Additionally, the mechanism by which SEn binds hPg is poorly understood. In this study, we show that SEn is exported via lipid microvesicles (MV), likely originating from the cytosolic membrane. Using cryogenic-electron microscopy, we provide a high-resolution (<3.4 Å) map of SEn reconstituted into dioleoyl phosphatidylglycerol (DOPG) liposomes, which serves as our MV model. The Sen-DOPG map reveals that two subunits of the SEn octamer are exposed to the extracellular medium, while six remain inserted within the membrane or vesicle interior. However, this interaction does not induce a conformational change in hPg, which remains in a closed conformation, thereby limiting the SEn stimulatory effect on many hPg activators, except for host tissue-type plasminogen activator (tPA). Instead, the ability of SEn to bind tPA is the primary factor driving enhanced hPg activation. These findings highlight a novel mechanism by which MV-associated SEn promotes hPg activation preferentially through tPA, independent of a hPg conformational rearrangement.

  • Open Access

    Hydrophobic residues in the D‐domain of a plasminogen‐binding M‐protein modulate α‐helicity, oligomerization, and surface anchoring in Streptococcus pyogenes

    by Olawole Ayinuola, Yetunde A. Ayinuola, Zhong Liang, Francis J. Castellino

    Human plasminogen (hPg) binding M‐protein (PAM) is a major virulence determinant of Group A Streptococcus (GAS). PAM contains irregularly spaced heptad repeats, particularly within its C‐ and D‐domains. Our recent cryo‐EM structure of PAM from GAS strain AP53 (PAMAP53) revealed that these repeats do not favor coiled‐coil formation, but instead adopt triple‐helix bundle and helix–loop–helix motifs in the C‐ and D‐domains, respectively. Interactions between loops connecting helices in these domains maintain the compact conformation of PAMAP53, correctly orienting human plasminogen (hPg) for activation by the co‐expressed streptokinase variant, SK2b. Despite the D‐domain being conserved across M‐proteins, its specific structural and functional roles remain unknown. To investigate the role of the D‐domain in PAM structure–function, we engineered three structure‐guided PAMAP53 variants, replacing nine heptad D‐domain residues with glycine (9G), alanine (9A), or leucine (9L). At 25°C, wild‐type (WT)‐PAMAP53 exists as a concentration‐ and temperature‐dependent mixture of dimers, tetramers, and higher‐order oligomers, which dissociate at physiological temperature. In contrast, PAMAP53‐9A and PAMAP53‐9L form thermostable oligomers while helix‐destabilizing PAMAP53‐9G exists as a monomer exhibiting structural loss at all temperatures. All variants retained high hPg‐binding affinity. However, unlike WT‐PAMAP53, PAMAP53‐9A, and PAMAP53‐9L, PAMAP53‐9G poorly stimulated hPg activation. Moreover, whereas WT‐PAMAP53, PAMAP53‐9A, and PAMAP53‐9L were covalently attached to the bacterial cell wall and displayed on the cell surface, PAMAP53‐9G, with a significantly reduced helical content, was not exposed on the bacterial surface. Our results reveal the importance of the D‐domain to secondary/quaternary structure, attachment of PAMAP53 to the GAS surface, and SK2b‐mediated activation of hPg.

  • Open Access

    Group a Streptococcus remains viable inside fibrin clots and gains access to human plasminogen for subsequent fibrinolysis and dissemination

    by Henry M. Vu, Thomas E. Moran, Zhong Liang, Yun-Juan Bao, Paulina G. Carles, Jessica C. Keane, Madelyn G. Cerney, Caitlyn N. Dahnke, Ana L. Flores-Mireles, Victoria A. Ploplis, et al.

    Group A Streptococcus (GAS) is a major human pathogen that causes several invasive diseases including necrotizing fasciitis. The host coagulation cascade initiates fibrin clots to sequester bacteria to prevent dissemination into deeper tissues. GAS, especially skin-tropic bacterial strains, utilize specific virulence factors, plasminogen binding M-protein (PAM) and streptokinase (SK), to manipulate hemostasis and activate plasminogen to cause fibrinolysis and fibrin clot escape. A major unresolved question regards the temporal dynamics of how GAS enmeshed in a fibrin clot can access plasminogen for clot dissolution and eventual dissemination. Here, we reveal through live imaging studies that GAS trapped inside a fibrin clot can remain viable in a latent state, until access to plasminogen activates fibrinolysis and dissemination. RNA-sequencing (RNA-seq) analysis shows marked changes in the wild-type (WT)-GAS transcriptome from the time bacteria were enmeshed inside the clot (4 h) to when dissemination was initiated (8 h). To gain a more fully realized model of how GAS trapped in fibrin clots can disseminate in the blood system, we utilized a novel 3D endothelial microfluidic device to demonstrate that GAS is fully capable of fibrinolysis in an endothelial environment, revealing a major underappreciated route by which GAS may cause more invasive outcomes. Our findings reveal for the first time that GAS can engage a latent, growth-suspended phase whereby physical structures such as fibrin clots that immobilize an invading pathogen allow bacteria to remain viable until sufficient access to plasminogen allows it to initiate fibrinolysis and escape into surrounding blood system and tissues. IMPORTANCE: Group A Streptococcus (GAS) is a human-specific bacterial pathogen that causes infections ranging in severity from mild to severe infections that can often be fatal. To protect the host, the innate immune system creates fibrin clots to trap bacteria and prevent deeper spread. GAS produces several factors that can initiate the dissolution of these fibrin clots to spread to deeper tissues, but we lack specific understanding of the timing of these events. Our studies demonstrate for the first time that GAS can delay their escape from fibrin clots to gain access to deeper tissues during infection, suggesting a key strategy that GAS utilize to cause more invasive disease.


  • High-resolution cryo-EM analysis of a Streptococcus pyogenes M-protein/human plasminogen complex

    by Bradley M. Readnour, Sheiny Tjia-Fleck, Nathan R. McCann, Yetunde A. Ayinuola, Francis J. Castellino


  • Open Access

    Interaction between Membrane-Bound Streptococcal Alpha-Enolase and Human Plasminogen Captured Through Cryogenic-Electron Microscopy

    by Sheiny Tjia-Fleck, Bradley N. Readnour, Zhong Liang, Yetunde A. Ayinuola, Francis J. Castellino

    Human plasminogen (hPg) is a single chain multi-modular zymogen containing five kringle domains (K1-K5), four of which interact with lysine. This characteristic is utilized by hPg and its activated product, plasmin (hPm), to interact with receptors containing COOH-terminal lysine residues or through-space isosteric pseudo-lysine residues. In the case of Gram-positive bacteria, Streptococcus pyogenes (GAS), hPg/hPm receptors are primarily focused around the multicopy surface-resident M-protein that is used to characterize the GAS substrain, or other surface proteins, such as the homooctameric glycolytic enzyme enolase (SEn). SEn has no features that suggest the mechanism of its transport from its normal location in the cytoplasm to the cell surface, but we find herein that SEn is translocated to the cell surface by lipid microvesicles (MV) most likely originating from the cytosolic membrane. Through the use of cryogenic-electron microscopy, we provide a high-resolution (<3.8Å) structure of SEn and SEn-hPg embedded in small DOPG unilamellar vesicles as a model system for MV-SEn. The structure predominantly shows that two subunits of the SEn octamer are exposed to the extracellular medium and six subunits are buried within the membrane and vesicular interior. While soluble SEn does not meaningfully interact with hPg, due to the steric unavailability of the COOH-terminal lysine residue of SEn, hPg can interact with SEn in DOPG vesicles, primarily via the hPg-K1 lysine binding site. Nonetheless, SEn does not place hPg in a favorable conformation for facile activation and this lack of conformational rearrangement is the primary reason for the attenuated enhancement of hPg activation when bound to the SEn octamer.

  • Open Access

    Plasminogen missense variants and their involvement in cardiovascular and inflammatory disease

    by Teresa Brito-Robinson, Yetunde A. Ayinuola, Victoria A. Ploplis, Francis J. Castellino

    Human plasminogen (PLG), the zymogen of the fibrinolytic protease, plasmin, is a polymorphic protein with two widely distributed codominant alleles, PLG/Asp453 and PLG/Asn453. About 15 other missense or non-synonymous single nucleotide polymorphisms (nsSNPs) of PLG show major, yet different, relative abundances in world populations. Although the existence of these relatively abundant allelic variants is generally acknowledged, they are often overlooked or assumed to be non-pathogenic. In fact, at least half of those major variants are classified as having conflicting pathogenicity, and it is unclear if they contribute to different molecular phenotypes. From those, PLG/K19E and PLG/A601T are examples of two relatively abundant PLG variants that have been associated with PLG deficiencies (PD), but their pathogenic mechanisms are unclear. On the other hand, approximately 50 rare and ultra-rare PLG missense variants have been reported to cause PD as homozygous or compound heterozygous variants, often leading to a debilitating disease known as ligneous conjunctivitis. The true abundance of PD-associated nsSNPs is unknown since they can remain undetected in heterozygous carriers. However, PD variants may also contribute to other diseases. Recently, the ultra-rare autosomal dominant PLG/K311E has been found to be causative of hereditary angioedema (HAE) with normal C1 inhibitor. Two other rare pathogenic PLG missense variants, PLG/R153G and PLG/V709E, appear to affect platelet function and lead to HAE, respectively. Herein, PLG missense variants that are abundant and/or clinically relevant due to association with disease are examined along with their world distribution. Proposed molecular mechanisms are discussed when known or can be reasonably assumed.


  • Open Access

    Fibrinolytic-deficiencies predispose hosts to septicemia from a catheter-associated UTI

    by Jonathan J. Molina, Kurt N. Kohler, Christopher Gager, Marissa J. Andersen, Ellsa Wongso, Elizabeth R. Lucas, Andrew Paik, Wei Xu, Deborah L. Donahue, Karla Bergeron, et al.

    Catheter-associated urinary tract infections (CAUTIs) are amongst the most common nosocomial infections worldwide and are difficult to treat partly due to development of multidrug-resistance from CAUTI-related pathogens. Importantly, CAUTI often leads to secondary bloodstream infections and death. A major challenge is to predict when patients will develop CAUTIs and which populations are at-risk for bloodstream infections. Catheter-induced inflammation promotes fibrinogen (Fg) and fibrin accumulation in the bladder which are exploited as a biofilm formation platform by CAUTI pathogens. Using our established mouse model of CAUTI, here we identified that host populations exhibiting either genetic or acquired fibrinolytic-deficiencies, inducing fibrin deposition in the catheterized bladder, are predisposed to severe CAUTI and septicemia by diverse uropathogens in mono- and poly-microbial infections. Furthermore, here we found that Enterococcus faecalis, a prevalent CAUTI pathogen, uses the secreted protease, SprE, to induce fibrin accumulation and create a niche ideal for growth, biofilm formation, and persistence during CAUTI.